Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 285

1.

The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks.

Deer TR, Pope JE, Hayek SM, Lamer TJ, Veizi IE, Erdek M, Wallace MS, Grider JS, Levy RM, Prager J, Rosen SM, Saulino M, Yaksh TL, De Andrés JA, Abejon Gonzalez D, Vesper J, Schu S, Simpson B, Mekhail N.

Neuromodulation. 2017 Feb;20(2):155-176. doi: 10.1111/ner.12579. Epub 2017 Jan 2. Review.

PMID:
28042914
2.

The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines.

Deer TR, Pope JE, Hayek SM, Bux A, Buchser E, Eldabe S, De Andrés JA, Erdek M, Patin D, Grider JS, Doleys DM, Jacobs MS, Yaksh TL, Poree L, Wallace MS, Prager J, Rauck R, DeLeon O, Diwan S, Falowski SM, Gazelka HM, Kim P, Leong M, Levy RM, McDowell G II, McRoberts P, Naidu R, Narouze S, Perruchoud C, Rosen SM, Rosenberg WS, Saulino M, Staats P, Stearns LJ, Willis D, Krames E, Huntoon M, Mekhail N.

Neuromodulation. 2017 Feb;20(2):96-132. doi: 10.1111/ner.12538. Epub 2017 Jan 2. Review.

PMID:
28042904
3.
4.

Psychosocial factors predict opioid analgesia through endogenous opioid function.

Burns JW, Bruehl S, France CR, Schuster E, Orlowska D, Buvanendran A, Chont M, Gupta RK.

Pain. 2017 Mar;158(3):391-399. doi: 10.1097/j.pain.0000000000000768.

PMID:
27898491
5.

[Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].

Noufi P, Khoury E, Ayoub E, Naccache N, Richa S.

Encephale. 2016 Dec;42(6):511-516. doi: 10.1016/j.encep.2016.05.010. Epub 2016 Oct 21. French.

PMID:
27776797
6.

Use of Methadone as an Adjuvant Medication to Low-Dose Opioids for Neuropathic Pain in the Frail Elderly: A Case Series.

Vu Bach T, Pan J, Kirstein A, Grief CJ, Grossman D.

J Palliat Med. 2016 Dec;19(12):1351-1355. Epub 2016 Oct 11.

PMID:
27726521
7.

[Dose-finding for treatment with a transdermal fentanyl patch : Titration with oral transmucosal fentanyl citrate and morphine sulfate].

Mücke M, Conrad R, Marinova M, Cuhls H, Elsner F, Rolke R, Radbruch L.

Schmerz. 2016 Dec;30(6):560-567. German.

PMID:
27072143
8.

Analgesic drugs and the gut - a reciprocal relationship.

Lawrence R.

J R Coll Physicians Edinb. 2015;45(4):284-8. doi: 10.4997/JRCPE.2015.408.

PMID:
27070892
9.

Intrathecal Drug Delivery Systems for Noncancer Pain: A Health Technology Assessment.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2016 Jan 29;16(2):1-77. eCollection 2016.

10.

Intrathecal Morphine Infusion Therapy in Management of Chronic Pain: Present and Future Implementation in Korea.

Kim EJ, Moon JY, Kim YC, Park KS, Yoo YJ.

Yonsei Med J. 2016 Mar;57(2):475-81. doi: 10.3349/ymj.2016.57.2.475.

11.

Pharmacokinetic Profile and Sustained 24-hour Analgesia of a Once-daily Hydrocodone Bitartrate Extended-release Tablet with Abuse-deterrent Properties.

Kapil RP, Cipriano A, Wen W, Yu Lynch S, He E, Colucci SV, Harris SC.

Clin Ther. 2016 Feb;38(2):302-14. doi: 10.1016/j.clinthera.2015.12.003. Epub 2015 Dec 31.

12.

Successful interventions in decreasing oxycodone CR prescriptions within an underserved population.

Shah NR, Haddad-Lacle J, Hogan T.

J Opioid Manag. 2015 Nov-Dec;11(6):481-8. doi: 10.5055/jom.2015.0301.

PMID:
26728645
13.
14.

How to Maximize Patient Safety When Prescribing Opioids.

Kirpalani D.

PM R. 2015 Nov;7(11 Suppl):S225-35. doi: 10.1016/j.pmrj.2015.08.016. Review.

PMID:
26568502
15.

Trialing and Maintenance Dosing Using a Low-Dose Intrathecal Opioid Method for Chronic Nonmalignant Pain: A Prospective 36-Month Study.

Grider JS, Etscheidt MA, Harned ME, Lee J, Smith B, Lamar C, Bux A.

Neuromodulation. 2016 Feb;19(2):206-19. doi: 10.1111/ner.12352. Epub 2015 Oct 19.

PMID:
26477685
16.

Cognitive Effects and Sedation.

Dhingra L, Ahmed E, Shin J, Scharaga E, Magun M.

Pain Med. 2015 Oct;16 Suppl 1:S37-43. doi: 10.1111/pme.12912. Review.

PMID:
26461075
17.

Opioid Induced Hyperalgesia.

Yi P, Pryzbylkowski P.

Pain Med. 2015 Oct;16 Suppl 1:S32-6. doi: 10.1111/pme.12914. Review.

PMID:
26461074
18.

The Economic Impact of Opioid Use in the Management of Chronic Nonmalignant Pain.

Lipman A, Webster L.

J Manag Care Spec Pharm. 2015 Oct;21(10):891-9. Review.

19.

Prescription Opioid Use and Risk of Coronary Heart Disease, Stroke, and Cardiovascular Death Among Adults from a Prospective Cohort (REGARDS Study).

Khodneva Y, Muntner P, Kertesz S, Kissela B, Safford MM.

Pain Med. 2016 Mar;17(3):444-455. Epub 2016 Feb 8.

PMID:
26361245
20.

12-Month safety and effectiveness of once-daily hydrocodone tablets formulated with abuse-deterrent properties in patients with moderate to severe chronic pain.

Wen W, Taber L, Lynch SY, He E, Ripa S.

J Opioid Manag. 2015 Jul-Aug;11(4):339-56. doi: 10.5055/jom.2015.0283.

PMID:
26312961

Supplemental Content

Loading ...
Support Center